Proactively manage your pharmacy inventory
Manage your formulary budget
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Find generic entry opportunities
Anticipate generic drug launch
Drug patents …
… from Kazakhstan to Kalamazoo
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
|Mechanism of Action||Bradykinin B2 Receptor Antagonists |
|Tradename||Generic Name||Dosage||NDA||Application Type||Supplier||National Drug Code||Package Code||Package|
|INJECTABLE;SUBCUTANEOUS||022150||NDA||Shire US Manufacturing Inc.||54092-702||54092-702-01||1 SYRINGE, GLASS in 1 CARTON (54092-702-01) > 3 mL in 1 SYRINGE, GLASS|
|INJECTABLE;SUBCUTANEOUS||022150||NDA||Shire US Manufacturing Inc.||54092-702||54092-702-02||1 SYRINGE, GLASS in 1 CARTON (54092-702-02) > 3 mL in 1 SYRINGE, GLASS|
|Active Rx/OTC/Discontinued:||RX||Dosage:||INJECTABLE;SUBCUTANEOUS||Strength||EQ 30MG BASE/3ML (EQ 10MG BASE/ML)|
|Approval Date:||Aug 25, 2011||TE:||RLD:||Yes|
|Regulatory Exclusivity Expiration:||Aug 25, 2016|
|Regulatory Exclusivity Use:||NEW CHEMICAL ENTITY|
|Regulatory Exclusivity Expiration:||Aug 25, 2018|
|Regulatory Exclusivity Use:||ORPHAN DRUG EXCLUSIVITY|
|Patent:||5,648,333||Patent Expiration:||Jul 15, 2019||Product Flag?||Y||Substance Flag?||Y||Delist Request?|
|Patented Use:||TREATMENT OF PATHOLOGICAL STATE BY ANTAGONIZING BRADYKININ RECEPTOR INCLUDING TREATMENT OF ACUTE ATTACKS OF HEREDITARY ANGIOEDEMA (HAE)|
These historical archives are available as an add-on to one-year subscriptions.
See the Subscription Options for more information.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Patent No.||Patent Expiration|
Shire Orphan Therap
|INJECTABLE;SUBCUTANEOUS||022150-001||Aug 25, 2011||5,648,333||<disabled>|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.